|
Dietary Supplements Label Database (DSLD)
|
Resource Development
|
CDC, FDA
|
OD/DPCPSI/ODP, NLM, OD/DPCPSI/ODS
|
In response to congressional mandate, the NIH Office of Dietary Supplement (ODS), in collaboration with the National Library of Medicine, takes the lead on the development and maintenance of the DSLD. The database now contains over 65,000 labels, with new data accumulating at the rate of 1,000 labels per month. The DSLD will grow to include nearly all of the dietary supplement products in the U.S. All labels are verified yearly to ensure that they remain current. The DSLD provides product information that can be organized and searched by users. The primary users of this database are researchers who use the DSLD to help determine total nutrient intakes from food and supplements in populations they study. Health care providers use it to find the content of products their patients are taking.
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
This project is a collaboration between the NIH Clinical Center and the FDA that consists of developing software and establishing validations for the automated determination of marrow cellularity and enumeration of plasma cells identified by immunohistochemistry (IHC) using a CD138 antibody. This initial effort should serve as proof of principle for a broader plan to utilize IHC-based automated quantitation of different types of cells in bone marrow core biopsies for diagnosis, prognosis and therapy monitoring of marrow disorders.
|
|
Disaster Research Response Project
|
Research Initiative
|
ATSDR, CDC, FDA, OS
|
NIEHS, NLM
|
The NIH Disaster Research Response (DR2) Project is a pilot project aimed at creating an environmental health disaster research system through platforms of ready-to-go research data collection tools and a network of specially trained research responders. This project was developed and will be administered by the NIEHS and NLM. Elements of the system include epidemiologic questionnaires and clinical protocols, specially trained disaster researchers, environmental health disaster research networks, a reach-back roster of subject matter experts, and a support infrastructure that can be activated and deployed during public health emergencies and declared disasters. This effort will not only serve as a model for enhancing environmental health research responses, but will also provide invaluable lessons and platforms for others interested in advancing timely post-disaster research activities.
|
|
Dominantly Inherited Alzheimer''s Network (DIAN): International Network for the Identification, Evaluation, and Follow up of Families with Early Onset of Dominantly Inherited Alzheimer''s Disease
|
Research Initiative
|
FDA
|
NIA
|
This collaboration aims to set up an international network consisting of a consortium of scientific investigators that will have the responsibility to identify, recruit, evaluate, and follow-up individuals from families with early onset dominantly inherited Alzheimer’s Disease [i.e., families with the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) mutations or duplications or others still to be discovered].
|
|
Drug Induced Liver Injury Network (DILIN)
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK
|
Both a prospective and retrospective database containing cases of drug-induced liver disease, the Drug Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. One of the goals of the DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. The DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Three employees of FDA serve as ad hoc members on the committee overseeing the network activities.
|
|
Early Hearing Detection and Intervention
|
Meeting/ Workshop
|
CDC
|
NIDCD
|
This collaboration focuses on a teleconference sponsored by CDC.
|
|
Early Learning Interagency Policy Board (IPB)
|
Committee, Work group, Advisory group, or Task Force
|
ACF
|
NICHD, NIDA
|
The purpose of this workgroup is to collaborate with the Administration for Children and Families (ACF) in order to coordinate efforts in the area of preschool education, including research.
|
|
East Asia Viral Hepatitis and Liver Cancer Consortium
|
Other
|
CDC
|
NCI, NIAID, NIDDK
|
The consortium aims to coordinate and share human, financial, and technical resources to effectively and efficiently address research and public health action needs in the prevention and control of viral hepatitis and liver cancer. This is a trans-HHS collaboration working with the World Health Organization Western Pacific Region Office WHO/WPRO and Ministries of Health of several partner countries.
|
|
Ebola Clinical Research Response in West Africa
|
Research Initiative
|
CDC, FDA
|
NIAID
|
This is a research collaboration between FDA, NIH, and CDC to respond to the Ebola emergency in West Africa.
|
|
Electronic Research Administration (eRA)
|
Resource Development
|
AHRQ, CDC, FDA, SAMHSA
|
NINR, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM, OD/OER
|
The Electronic Research Administration (eRA) provides information technology solutions and support for the full life cycle of grants administration functions for the NIH as well as the Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the Veterans Health Administration (VHA). eRA offers vital solutions to manage the receipt, processing, review, award and monitoring of over $30 billion in research and non¬research grants awarded annually by NIH and other grantor agencies in support of the collective mission of improving human health. eRA helps NIH meet a vital mission: the support of cutting¬ edge biomedical research via grants to scientists at universities and other research institutions. Over 4,100 NIH staff, 729 partner agency staff, and 171,083 active external users depend on eRA daily. Used by Federal staff and applicants at over 28,400 research institutions worldwide, eRA has helped eliminate the hundreds of millions of pieces of paper previously required to: • Record, review and process over 89,600 applications each year. • Support more than 3,960 review meetings held annually. • Administer more than 61,200 awarded competing and non¬competing grants. • Maintain patent and invention records for 32 Federal agencies (see the iEdison website). • Support thousands of applicant interactions with the Federal Government before and after the grant award, through the eRA online interface. eRA''s focus is on supporting the mission of serviced agencies by providing tools to electronically manage and report on grants in a way that maximizes efficiencies, provides a strong and scalable infrastructure, is responsive to evolving customer needs and employs sound management controls. eRA systems align with Grants.gov (the one¬ stop web portal for finding and applying for federal grants), allowing for full electronic processing of grant applications from application submission through closeout of the grant award and reporting thereafter. eRA operates as a fee for service activity to OPDivs and other federal agencies.
|